Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 2,900 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Jun 26, 2025
Webinar · 30:32
Dr. Tom Mincherton. Research Officer, Childrens Cancer Institute Australia